<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Mirum Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Mirum Pharmaceuticals, Inc.

    Mirum Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company’s lead product candidate, maralixibat, is an investigational oral drug in development for progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome (ALGS). Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $345,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Peetz
    • FOUNDED
      2018
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Kodiak Sciences Inc

    Kodiak Sciences Inc

    Kodiak Sciences is a clinical stage company developing innovative therapeutics to ...

    Kodiak Sciences is a clinical stage company dev...

    Filing Type:    PU
    Delee Corp

    Delee Corp

    At Delee, we aim to radically change the way cancer is detected, monitored and tre...

    At Delee, we aim to radically change the way ca...

    Fundraising Status:    EC
    Filing Type:    CF
    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to im...

    Five Prime Therapeutics, Inc. discovers and dev...

    Filing Type:    PU
    CNS Pharmaceuticals, Inc

    CNS Pharmaceuticals, Inc

    CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in ...

    CNS Pharmaceuticals is a pre-clinical stage bio...

    Amount Raised:    $628,558
    Fundraising Status:    EC
    Filing Type:    CF
    Rigel Pharmaceuticals, Inc.

    Rigel Pharmaceuticals, Inc.

    Rigel Pharmaceuticals, Inc. is a biotechnology company dedicated to discovering, d...

    Rigel Pharmaceuticals, Inc. is a biotechnology ...

    Filing Type:    PU
    Evolus, Inc.

    Evolus, Inc.

    Evolus is a performance beauty company with a customer-centric approach focused on...

    Evolus is a performance beauty company with a c...

    Filing Type:    PU
    Gemphire Therapeutics Inc.

    Gemphire Therapeutics Inc.

    Gemphire Therapeutics Inc. (NASDAQ:GEMP) is a clinical‑stage biopharmaceutical c...

    Gemphire Therapeutics Inc. (NASDAQ:GEMP) is a c...

    Filing Type:    PU
    GENFIT S.A.

    GENFIT S.A.

    GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and de...

    GENFIT is a late-stage biopharmaceutical compan...

    Filing Type:    PU
    Dicerna Pharmaceuticals, Inc.

    Dicerna Pharmaceuticals, Inc.

    Dicerna is a biopharmaceutical company focused on the discovery and development of...

    Dicerna is a biopharmaceutical company focused ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.